Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | IDO1 | P14902 | 3/20 | 0.60 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.57 |
| ▸ | MAOB | P27338 | 7/20 | 0.54 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.51 |
| ▸ | PTPN2 | P17706 | 1/20 | 0.47 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.47 |
| ▸ | PTPN6 | P29350 | 1/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.42 |
| ▸ | TACR1 | P25103 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10458621 | 0.86 | IDO1 (0.57) | IDO1TAAR1MAOBKMT2APTPN2 | |
| SCHEMBL492736 | 0.83 | IDO1 (0.68) | IDO1TAAR1MAOBKMT2APTPN2 | |
| Hydroxyamine SCHEMBL8924228 | 0.82 | IDO1 (0.67) | IDO1TAAR1MAOBKMT2APTPN2 | |
| SCHEMBL13724236 | 0.81 | IDO1 (0.55) | IDO1TAAR1MAOBKMT2APTPN2 | |
| SCHEMBL13737507 | 0.81 | IDO1 (0.55) | IDO1TAAR1MAOBKMT2APTPN2 | |
| SCHEMBL10264232 | 0.81 | IDO1 (0.55) | IDO1TAAR1MAOBKMT2APTPN2 | |
| SCHEMBL20444746 | 0.78 | IDO1 (0.52) | IDO1TAAR1MAOBKMT2APTPN2 | |
| SCHEMBL3434078 | 0.76 | IDO1 (0.59) | IDO1TAAR1MAOBKMT2APTPN2 | |
| SCHEMBL1771605 | 0.76 | IDO1 (0.59) | IDO1TAAR1MAOBKMT2APTPN2 | |
| SCHEMBL29226719 | 0.76 | IDO1 (0.59) | IDO1TAAR1MAOBKMT2APTPN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113354590-A | Quinazolinone compound for antagonizing NOD1/2 receptor signal pathway | 宁波康柏睿格医药科技有限公司 | 2021-09-07 | — | — | CN | disclosed |